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E-mail address: camselle@unex.es (J.C. Cameselle)Cyclic ADP-ribose (cADPR) metabolism in mammals is catalyzed by NAD glycohydrolases (NADases)
that, besides forming ADP-ribose, form and hydrolyze the N1-glycosidic linkage of cADPR. Thus far,
no cADPR phosphohydrolase was known. We tested rat ADP-ribose/CDP-alcohol pyrophosphatase
(ADPRibase-Mn) and found that cADPR is an ADPRibase-Mn ligand and substrate. ADPRibase-Mn
activity on cADPR was 65-fold less efﬁcient than on ADP-ribose, the best substrate. This is similar
to the ADP-ribose/cADPR formation ratio by NADases. The product of cADPR phosphohydrolysis
by ADPRibase-Mn was N1-(5-phosphoribosyl)-AMP, suggesting a novel route for cADPR turnover.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction linkages of ADP-ribose, CDP-alcohols and ADP with decreasing efﬁ-Cyclic ADP-ribose (cADPR) is a universal Ca2+ regulator formed
by enzymes of the ADP-ribosyl cyclase family [1] including Aplysia
soluble ADP-ribosyl cyclase [2], the mammalian membrane-bound
NAD glycohydrolases (NADases) CD38 [3–9], BST-1/CD157 [10,11],
and the mitochondrial NADase [12]. They form a glycosidic linkage
between the adenine N1 and the distal-ribose C1 atoms of NAD,
converting it to cADPR and nicotinamide. For CD38, the most stud-
ied mammalian ADP-ribosyl cyclase, this is a quantitatively minor
activity, compared to the hydrolysis of NAD to ADP-ribose. Those
enzymes catalyze also the hydrolysis of cADPR to ADP-ribose, the
only known pathway for cADPR turnover.
Mn2+-dependent ADP-ribose/CDP-alcohol pyrophosphatase
(ADPRibase-Mn) (EC 3.6.1.53) hydrolyze the phosphoanhydridechemical Societies. Published by E
DP-ribose/CDP-alcohol pyro-
thylsulfoxide; NADase, NAD
enosine; pRib-AMP, N1-(5-
-ATP, N1-(5-phosphoribosyl)-
osine; Rib-AMP, N1-(ribosyl)-
.ciencies, requiring low micromolar Mn2+ concentrations not
substituted by Mg2+ [13]. It may constitute a metallophosphoester-
ase family of its own, speciﬁc to vertebrates, plants and algae. In
rodents, it is expressed preferentially in immune cells [14], with
a possible signalling role inferred from the roles of its expression
proﬁle neighbors, i.e. the genes displaying the most similar expres-
sion proﬁles [14,15], and from the activatory effect of its best
substrate, ADP-ribose, on TRPM2 ion channels [16,17]. Like ADP-ri-
bose, cADPR is a TRPM2 (co)activator [18]; therefore, we decided to
test cADPR as an ADPRibase-Mn ligand and substrate.2. Materials and methods
2.1. Materials
cADPR, D-xylulose-5-phosphate and thiamine pyrophosphate
were from Sigma, and NAD and D-ribose-5-phosphate were from
Boehringer (Roche). cADPR was dissolved in 50 ll water per 0.5-
mg vial and frozen at 20 C until used. When indicated, to remove
ADP-ribose contamination, 50 mM Tris–HCl (pH 7.5) substituted
for water, and the solution was treated with 50 ng of venom phos-
phodiesterase and 60 ng of alkaline phosphatase for 4 h at 25 C
followed by overnight incubation at 4 C. This left cADPR intactlsevier B.V. All rights reserved.
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cADPR was puriﬁed by HPLC (see below).
Standard N1-(5-phosphoribosyl)-adenosine 50-monophosphate
(pRib-AMP) was prepared by dilution of 1 ll of 20 mM cADPR in
125 ll of dimethylsulfoxide (DMSO) containing 1 mg of tert-butox-
ide, and incubation for 60–120 min at 37 C. This treatment hydro-
lyzes the phosphoanhydride linkage of cADPR to pRib-AMP [19]. In
our hands, it gave full conversion of contaminant ADP-ribose to
AMP and partial conversion of cADPR to pRib-AMP (HPLC analysis).
Potassium tert-butoxide was from Aldrich and DMSO (99.9%) was
from Sigma.
Rat ADPRibase-Mn was expressed from plasmid pGEX-6P-3-
rADPRMn and puriﬁed as described [14]. Snake venom phosphodi-
esterase (from Crotalus durissus) was from Boehringer, alkaline
phosphatase (grade I from calf intestine) was from Roche, and
AMP deaminase (from Aspergillus sp.), transketolase (from baker’s
yeast) and glyceraldehyde 3-phosphate dehydrogenase (from rab-
bit muscle) were purchased from Sigma. Other (bio)chemicals
were as described [14].
2.2. ADPRibase-Mn incubations
Assay mixtures contained 50mM Tris–HCl (pH 7.5 at 25 C),
100 lMMnCl2, 0.1 mg/ml BSA, cADPR as indicated and an appropri-
ate ADPRibase-Mn concentration. The formation of pRib-AMP was
measured by HPLC after deﬁned incubation lengths at 37 C termi-
nated by injection in the column (see below). Initial rate assays were
performed under conditions of linearity with incubation length and
ADPRibase-Mn amount, and blanks without ADPRibase-Mn were
run in parallel.
2.3. HPLC
A 15 cm  0.4 cm octadecylsilica column (Kromasil 100, Tek-
nokroma, Spain) was used with a 1 cm  0.4 cm guard column of
the same material, under the control of a Hewlett-Packard
HP1100 chromatograph equipped with a diode array detector.
For analytical purposes, samples were analyzed by ion-pair re-
verse-phase HPLC monitored at 260 nm and 310 nm. On selected
occasions, the diode array detector was programmed to record full
ultraviolet–visible spectra. The column was equilibrated in
33.5 mM sodium phosphate, pH 8.5, 20 mM tetrabutylammonium
bromide and 10% (vol/vol) methanol. After sample injection
(20 ll), the elution was run at 1 ml/min with a 10-min linear gra-
dient of 33.5–62 mM phosphate, followed by an isocratic wash
with 62 mM phosphate (the pH and the rest of components of
the initial mobile phase were kept constant). The use of a mobile
phase at pH 8.5 allowed for the speciﬁc detection of compounds
containing N1-(ribosyl)-adenosine (Rib-Ado), like cADPR and
pRib-AMP, as at pH 8.5 (but not e.g. at pH 7.0) solutions of those
compounds show e310 much higher than plain adenosine deriva-
tives like ADP-ribose or AMP [19–21].
For cADPR puriﬁcation, the HPLC column was equilibrated in
water, and a 15-ll sample of treated cADPR (see Section 2.1) was
chromatographed at 0.5 ml/min in water with monitoring at
260 nm and 310 nm. cADPR (retention time 4 min) was recovered
at the column outlet at a concentration of 0.5 mM. It was judged
99.9% pure from analytical HPLC chromatograms at 260 nm.
2.4. Enzymatic assays of AMP and D-ribose-5-phosphate formed by
heating pRib-AMP, the product of hydrolysis of cADPR by ADPRibase-
Mn
AMPwas measured by enzyme end-point assay in reaction mix-
tures of 0.6 ml containing 10 mM sodium citrate, pH 6.5, and
33 mM KCl. After recording a baseline at 265 nm, the assay was ini-tiated by addition of 1 ll of AMP deaminase (freshly prepared dis-
solving 10 mg in 0.1 ml 1 M KCl) and the decrease of A265
concomitant to the conversion of AMP to IMP (e = 8.1 mM1 cm1)
was recorded until a new baseline was reached. The increase of
A265 caused by the enzyme itself was determined and used to cal-
culate the true decrease due to AMP deamination.
D-ribose-5-phosphate was measured by kinetic assay of its
reaction with 35 lM D-xylulose-5-phosphate catalyzed by trans-
ketolase in 0.6-ml mixtures containing 25 mM glycylglycine, pH
7.3, 5 mM MgCl2, 0.22 mM thiamine pyrophosphate, 5 mM so-
dium arsenate, 1 mM NAD, 0.1 mg/ml bovine serum albumin,
5 lg/ml transketolase (dissolved in 250 mM glycylglycine, pH
7.3) and 60 m-unit D-glyceraldehyde-3-phosphate dehydrogenase
(pre-assayed under these conditions with 80 lM D-glyceralde-
hyde-3-phosphate as substrate). Transketolase forms one mole
of D-glyceraldehyde-3-phosphate per mole of D-xylulose-5-phos-
phate either by monosubstrate reaction or by bisubstrate reaction
with D-ribose-5-phosphate [22,23]. The formation of D-glyceralde-
hyde-3-phosphate is coupled to its arsenate and NAD-dependent
oxidation catalyzed irreversibly by D-glyceraldehyde-3-phosphate
dehydrogenase. Under the chosen conditions, the initial rate of
NAD reduction, started by addition of D-xylulose-5-phosphate
and recorded at 340 nm (e = 6.22 mM1 cm1), was linearly re-
lated to the concentration of D-ribose-5-phosphate present in
the mixture at least in the range 0-25 lM. The concentration of
D-ribose-5-phosphate formed by heating the reaction product of
ADPRibase-Mn was thus determined in a sample volume that
would give an analyte concentration within the linearity range,
and a calibration plot with standard amounts of D-ribose-
5-phosphate 0-25 lM was obtained for each assay session. In this
system, D-ribose did not react as, when added up to a concentra-
tion of 1 mM, it did not alter appreciably the slope recorded at
340 nm with D-xylulose-5-phosphate alone.
All the samples and standards were assayed in duplicate. Since
the preparation of the samples for AMP and D-ribose-5-phosphate
assays involved incubation in a boiling water bath for 15 min, the
recovery of the two compounds was evaluated: 101 ± 1% of AMP,
but only 63 ± 2% of D-ribose-5-phosphate (n = 3) was recovered
after the treatment. Therefore, the measurements of D-ribose-5-
phosphate were corrected as needed.
2.5. Structural models and AutoDock simulations
The coordinates of rat ADPRibase-Mn, modelled by homology to
the X-ray structure of its zebraﬁsh ortholog, were taken from the
SWISS-MODEL repository (accession code q5m886) [24,25]. The
ADPRibase-Mn model was prepared for docking as described
[14], including two Zn2+ ions, present in the zebraﬁsh protein,
which form a dinuclear center typical of the metallophosphoester-
ase superfamily. The preparation of the structure of ADP-ribose
and its docking to the ADPRibase-Mn model with AutoDock
[26,27] has been also reported [14]. The structure of cADPR was
generated with Marvin 5.0.1 (updated 2008; ChemAxon, Budapest,
Hungary, http://www.chemaxon.com) and its partial Gasteiger
charges were calculated with AutoDockTools [28] (total charge:
2). To overcome the limitation of AutoDock in treating ﬂexible
cyclic and macrocyclic ligands, like cADPR, an approach for intro-
ducing ring ﬂexibility in docking with AutoDock 3.0.5 was imple-
mented at source code level in AutoDock 4.0.1. Brieﬂy, the ring
was broken between the C4 and C5 atoms of N1-ribose, and a mod-
iﬁed potential function was applied between them to bias the con-
formational search toward ring closure [29]. The two ribose rings
of cADPR were modelled as rigid moieties to reduce the conforma-
tional search space. Otherwise, the parameters to run cADPR dock-
ing simulations with the modiﬁed version of AutoDock 4.0.1 were
as described for ADP-ribose docking [14].
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3.1. cADPR docking to a model of ADPRibase-Mn and molecular-
dynamics simulation
To test cADPR as ADPRibase-Mn ligand, we used a computa-
tional approach. The active center of ADPRibase-Mn, as indicated
by the binding of Pi in the X-ray structure and of ADP-ribose in a
docked model, is a pocket that is partly closed by two amino
acid-loops (36–41 and 196–211) and that contains the dimetallic
center in the bottom [14]. After a docking simulation with Auto-
Dock, cADPR ﬁt also into this site. Whereas the adenosine and
the ribose moieties of ADP-ribose protrude towards opposing sides
[14], cADPR remained in a more retracted position with the ade-
nine centered within the pocket, above the pyrophosphate group
(Fig. 1). The pyrophosphate groups of cADPR and ADP-ribose occu-
py practically the same position, with the phosphate esteriﬁed to
the northern ribose (the one attached to the N1 of adenine) being
coordinated to both metallic ions. This conﬁrmed that the ADPRi-
base-Mn complex with cADPR could represent an enzyme-sub-
strate complex for hydrolysis of the phosphoanhydride linkage,
like with ADP-ribose.
ADPRibase-Mn complexes with docked ligands show the active
center in a closed conformation (Fig. 1). To explore whether other
conformations could at least theoretically exist, we ran molecular-
dynamics simulations with the ADPRibase-Mn/cADPR complex
(online Supplementary material). This revealed novel, more open
conformations of the active center that may allow for substrate en-
try (Supplementary Fig. S1). The occurrence of theoretical, open
and closed conformations suggest a hypothetical induced ﬁt. Alto-
gether, the results of computational docking and dynamics urged
us to test experimentally whether cADPR was an ADPRibase-Mn
substrate.Fig. 1. ADPRibase-Mn complexes with cADPR and ADP-ribose. Both ligands were
docked to the same ADPRibase-Mn model with AutoDock. The ﬁgure shows the
overlapped structures of cADPR (yellow) and ADP-ribose (green). Black or grey
spheres correspond to the ions in the dimetallic center. The docking of ADP-ribose is
as reported [14]. (A) Full view. (B) Molecular surface of the active center as viewed
from above in A. (C) Overlapped structures of cADPR and ADP-ribose in the active
center showing the coincidence of the respective pyrophosphate groups in the
lower part (P atoms of cADPR and ADP-ribose are represented by the small orange
and green balls, respectively, and are marked by arrows).3.2. Conversion of cADPR to pRib-AMP by incubation with ADPRibase-
Mn
Incubation of cADPR with ADPRibase-Mn in the presence of
Mn2+, produced a compound different to cADPR and ADP-ribose
(peak with a retention time of near 9 min in Fig. 2). Contrary
to ADP-ribose or AMP, which do not absorb at 310 nm, the un-
known product displayed a signiﬁcant A310/A260 ratio (0.15) sim-
ilar to cADPR (Fig. 3). Since the difference between the
ultraviolet spectra of cADPR and ADP-ribose depends on the
N1-glycosidic linkage of the former [21], the unknown product
should still contain this linkage. It seemed thus likely that
ADPRibase-Mn was hydrolyzing the phosphoanhydride linkage
of cADPR, and that the reaction product was pRib-AMP (Fig. 4).
The identiﬁcation of pRib-AMP was conﬁrmed by coelution with
the compound produced chemically from cADPR (Fig. 2), and by
structural characterization by enzymatic assays. These experi-
ments were performed on standard ADPRibase-Mn reaction mix-
tures prepared with puriﬁed cADPR and incubated at 37 C until
all the substrate was transformed.
To determine the content of terminal phosphate groups in the
ADPRibase-Mn reaction product, samples taken from 0.3-ml reac-
tion mixtures containing 30 nmol of hydrolyzed cADPR were incu-
bated with alkaline phosphatase (250 ng of enzyme added,
followed by 20-min incubation at 37 C, in 0.1 ml of 50 mM Tris
pH 7.5) and Pi was assayed with an ascorbate-molybdate reagent
as described [13]. In this way, 1.91 ± 0.03 mol (n = 3) of Pi was mea-
sured per mole of cADPR hydrolyzed by ADPRibase-Mn. In the ab-
sence of added alkaline phosphatase, only 0.13 ± 0.04 mol were
measured. In contrast to the reaction product, cADPR itself is resis-
tant to alkaline phosphatase. This indicates that ADPRibase-Mnhydrolyzes one of the phosphate linkages of cADPR giving a prod-
uct with two phosphomonoesterase-sensitive phosphate groups.
Fig. 2. HPLC detection of the hydrolysis product of cADPR by ADPRibase-Mn:
coelution with pRib-AMP produced by chemical hydrolysis of cADPR. A reaction
mixture of ADPRibase-Mn (10 lg/ml) with 100 lM commercial cADPR containing a
18% contamination by ADP-ribose (control) was incubated under standard condi-
tions. Samples of 20 ll were taken after 1-min, 30-min and 60-min incubations and
were analyzed by HPLC. For identiﬁcation of the ADPRibase-Mn product as pRib-
AMP, another sample of reaction mixture incubated for 75 min was coeluted with a
sample of chemically hydrolyzed cADPR in a 1:3 proportion (see Section 2.3).
Fig. 3. Ultraviolet spectrum of the ADPRibase-Mn product identiﬁed as pRib-AMP.
The spectrum of AMP is shown for comparison. Spectra were recorded at pH 8.5
from HPLC peaks (see Fig. 2).
Fig. 4. Phosphohydrolysis of cADPR catalyzed by ADPRibase-Mn. The phosphohy-
drolytic pattern of the reaction and the identiﬁcation of the product as pRib-AMP is
supported by the demonstration that (i) the product contains two phosphate groups
releasable by alkaline phosphatase, while the substrate has none, (ii) the UV
spectrum of the product at pH 8.5 is like that of cADPR including the shoulder
around 300 nm typical of the N1-glycosydic linkage with the adenine base, and (iii)
the incubation of the product for 15 min in a boiling bath converted it to AMP and
D-ribose-5-phosphate.
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ribose-5-phosphate and AMP, 0.4-ml samples of ADPRibase-Mn
reaction mixture containing 80 nmol of hydrolyzed cADPR were
incubated for 15 min in a boiling bath to hydrolyze the N1-glyco-
sidic linkage expected to be present in the reaction product as is
in cADPR [3]. Enzymatic assays showed the formation of
0.97 ± 0.08 mol AMP and 1.00 ± 0.04 mol D-ribose-5-phosphate
(n = 3) per mole of cADPR hydrolyzed by ADPRibase-Mn and then
heated. The formation of AMP, not adenosine or ADP, was also con-
ﬁrmed by HPLC assay. This indicates that the phosphoanhydride
linkage of cADPR is indeed the one attacked by ADPRibase-Mn
and the product is pRib-AMP (Fig. 4).
3.3. Catalytic efﬁciency of the cADPR pyrophosphatase activity of
ADPRibase-Mn
ADPRibase-Mn hydrolyzes ADP-ribose, CDP-choline, CDP-glyc-
erol and CDP-ethanolamine with decreasing catalytic efﬁciencies
as estimated from kcat/Km ratios derived from saturation parame-
ters [14]. For comparison of cADPR to the other ADPRibase-Mn
substrates, saturation curves for cADPR were run with the com-
mercial cADPR preparation contaminated with ADP-ribose. In theHPLC assays, monitored by HPLC at 260 nm and 310 nm, the con-
taminant ADP-ribose was consumed rapidly (see e.g. Fig. 2) allow-
ing the measurement of linear rates of cADPR hydrolysis without
Fig. 5. Saturation kinetics of the phosphohydrolytic activity of ADPRibase-Mn
towards cADPR. The results of two different experiments are plotted together and
adjusted to the Michaelis–Menten equation by non-linear regression [39].
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ADPRibase-Mn with cADPR, which gave a Km value of
170 ± 30 lM and a kcat of 0.87 ± 0.04 s1. The resultant catalytic
efﬁciency or cADPR speciﬁcity constant, kcat/Km, is thus near
5000 M1 s1, 65-fold lower than that of ADP-ribose [14]. This re-
sult was conﬁrmed with puriﬁed cADPR, devoid of ADP-ribose con-
tamination. In this case, the kcat/Km ratio was estimated from initial
rate measurements at substrate concentrations well below the
estimated Km value, when the enzyme is largely unbound to sub-
strate and the catalytic efﬁciency or speciﬁcity constant is given
by (kcat/Km) = v/([E]0[S]), E0 being the total enzyme concentration
[30]. By this method, the ADPRibase-Mn catalytic efﬁciency with
cADPR as substrate was estimated as 4160 ± 240 M1 s1, in very
good agreement with the result derived from saturation parame-
ters obtained with cADPR contaminated by ADP-ribose.
4. Discussion
This is the ﬁrst report of the enzymatic formation of pRib-AMP
in mammals. In prokaryotes, lower eukaryotes and plants, it is an
intermediate of histidine biosynthesis formed by hydrolysis of
N1-(5-phosphoribosyl)-adenosine 50-triphosphate (pRib-ATP)
[20,31,32], but its signiﬁcance in organisms that do not synthesize
histidine is unknown.
To our knowledge, this is also the ﬁrst report of the enzymatic
hydrolysis of the phosphoanhydride linkage of cADPR (Fig. 4), dif-
ferent to the hydrolysis of the N1-ribosyl linkage of cADPR to ADP-
ribose [3–9]. So far, the strategy of phosphohydrolytic turnover
seemed inoperant for cADPR, as no enzyme with cADPR phospho-
hydrolase activity was known. This includes cADPR resistance to
broad speciﬁcity phosphodiesterases [3,19]. The catalytic efﬁ-
ciency of ADPRibase-Mn for cADPR phosphohydrolysis is low com-
pared to other substrates (ADP-ribose, 328 200 M1 s1; CDP-
choline, 95 000 M1 s1; CDP-glycerol, 92 400 M1 s1; CDP-etha-
nolamine, 29 000 M1 s1, ADP, 21 400 M1 s1 [14]). However,
the ratio of efﬁciencies for ADP-ribose/cADPR hydrolysis near 100
is like the ratio of ADP-ribose/cADPR formation from NAD by
CD38 [3,6,33,34], the major cADPR-forming enzyme in mammals.
Therefore, the potential of ADPRibase-Mn for cADPR metabolism
should not be disregarded.
CD38 NADases and its products ADP-ribose and cADPR have a
role in immune regulation at the interface between the innate
and the adaptative systems [35,36]. Concerning ADPRibase-Mn,
mouse DNA microarray data indicate its encoding gene
2310004I24Rik is an ‘‘immune gene” [15], and enzyme levels are
higher in immune than in non-immune cells from rats [14]. ADPRi-
base-Mn could be involved in the CD38 network with a role in theturnover of ADP-ribose and cADPR, and in the termination of their
effects on TRPM2 channels in immune cells [18]. Moreover, it is
worth mentioning that the hydrolysis of cADPR by ADPRibase-
Mn could be the ﬁrst step of a pathway leading to compound(s)
(e.g. pRib-AMP, Rib-AMP, pRib-Ado, Rib-Ado) with a potential for
cell signaling, as many other adenine-containing derivatives
[37,38].
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